NEW YORK (GenomeWeb News) – Bulldog Bio today said that it has been given the exclusive rights to sell Australian firm GeneWorks's Acquire PCR Cloning technology in the US.
"The technology incorporated into the Acquire PCR Cloning Kit will provide our customers with the potential for extraordinary results from both A-tailed and blunt-ended PCR products, without the need for color selection," Ella Fontaine, vice president of communication for Bulldog Bio, said in a statement. "The Acquire kit's novel feature set, including a unique vector with three base overhang, enables rapid and efficient cloning, and the attractive price should make it one of our most popular products."
Terms of the deal were not disclosed.
Bulldog, based in Portsmouth, NH, distributes tools to life science researchers. GeneWorks, headquartered in Adelaide, Australia, supplies molecular biology research products and services.